Jeffrey S. Borer, M.D. is the Gladys and Roland Harriman Professor of Cardiovascular Medicine at Weill Medical College of Cornell University, where he also is Professor of Radiology and of Cardiothoracic Surgery, both in Cardiovascular Medicine, and, administratively, chairs the Section of Cardiovascular Pathophysiology and The Howard Gilman Institute for Valvular Heart Diseases at Cornell.
He received his undergraduate education at Harvard, his medical degree from Cornell, and his post-graduate training at the Massachusetts GeneralHospital and in the Cardiology Branch of the National Heart, Lung and Blood Institute of the NIH, where he subsequently established the Nuclear Cardiology service and served as its first Chief. He was a Senior Fulbright Hays Scholar and Glorney-Raisbeck Fellow in 1974-75 at Guy’s Hospital,University ofLondon, inLondon,England. In 1979, he returned to Cornell.
Dr. Borer is Editor-in-Chief of Cardiology, one of the world’s oldest peer-reviewed cardiovascular journals, and of Advances in Cardiology, and serves on the Editorial Boards of several major peer-reviewed journals. Since 1977 he has served continually as an Advisor/Consultant to the Cardio-Renal Division of the U.S.F.D.A., chairing the Cardio-Renal Advisory Committee for 3 separate terms, the last ending in 2004. He has authored a book on regulatory aspects of cardiovascular drug development and consults regularly for the pharmaceutical and devices industries. From 1984 through 2005 he served continually as an Advisor to NASA. He was President of the New York Cardiological Society in 1990-91, President of the New York State Chapter of the American College of Cardiology from 1997 to 1999, member of the Board of Governors of the American College of Cardiology from 1997-2000, member of Board of Governors of the Society of Cardiac Angiography and Interventions from 1995 to 2000, and member of the Board of Trustees of the Certification Board of Nuclear Cardiology from 1996 to 2002. Currently, he is President of the Heart Valve Society of America. He has authored 4 books and authored or co-authored more than 360 journal articles, reviews and chapters. His research achievements have included (1) establishment of the benefits of the drug, nitroglycerin, during acute myocardial infarction (1971-75); (2) development of real-time radionuclide cineangiography and its application during exercise (1976-1979); (3) development of non-invasive prognostic indices in patients with coronary artery and valvular diseases (1979-present); (4) exploration of the cellular and molecular bases of heart failure in regurgitant valvular diseases and other volume overload states (1984-present). He has received several peer recognitions including the Hans-Peter Krayenbeuhl Memorial Award of the International Society of Cardiology in 2002 and the Public Service Medal of the National Aeronautics and Space Administration in 1999.
